Company Legal Name
Latest Valuation
Founded Year
Headquarter
HongShan is a venture capital and private equity firm that invests in technology, healthcare, and consumer companies across Asia and Europe. Based in Shanghai, the firm focuses on backing high-growth startups and scale-up companies in key emerging markets. HongShan leverages its deep regional expertise and network to identify promising investment opportunities in sectors experiencing rapid digital transformation. The firm provides both capital and strategic guidance to portfolio companies seeking to expand their market presence and operational capabilities. HongShan continues to actively deploy capital across its target sectors, with particular emphasis on companies driving innovation in Asia's evolving technology landscape.
Revenue & Revenue Growth Share
Revenue
Revenue Growth
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.





